Functional studies have proven that ataxin2 interacts with TDP-43 via joint mRNA binding, aggravating TDP-43 toxicity and thereby further increasing the risk of developing ALS22. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis type 22.